News

Researchers find tirzepatide more effective than semaglutide for weight loss in a 72-week trial, with significant reductions ...
A new study has pitted Wegovy and Zepbound head-to-head in their ability to treat obesity. Published in The New England ...
Veru reports strong safety and efficacy for enobosarm added to semaglutide, showing reduced functional decline and muscle ...
In an effort to promote the use of genuine products, Novo Nordisk is offering a one-time first-month offer for Wegovy at $199 ...
Novo Nordisk will sell a less expensive one-month supply of Wegovy for patients who previously took compounded versions of ...
Federal regulators have accepted Novo Nordisk’s application to produce a pill version of its injectable weight-loss ...
As the FDA’s ban on mass compounding of semaglutide takes effect, Novo Nordisk introduces discounted pricing and new patient ...
Novo Nordisk boosts Wegovy access with discounts as FDA bans compounded semaglutide drugs and cracks down on weight-loss ...
When considering a weight loss medication — or any medication — it’s normal to wonder when the effects will kick in.
It's plainly apparent that Novo Nordisk has had May 22 circled its calendar since February, when the FDA began the countdown ...
The new weight-loss option will cut what the plan sponsors pay as well as what the patients pay, Cigna’s PBM Evernorth says.
The suit comes amid recent studies showing a link between vision complications and people taking drugs containing semaglutide ...